Dr. Dante J. Pieramici, MD

Dr. Pieramici practices at California Retina Consultants in Bakersfield, California.

Dr. Pieramici's NPI, 1992804504, was assigned on September 21, 2006. Dr. Pieramici graduated from The Johns Hopkins University School of Medicine in 1991. Dr. Pieramici holds California license C50523.

Dr. Pieramici's primary practice is California Retina Consultants, at 5555 Business S Park, Bakersfield, CA 93309 in Kern County. The practice phone is (661) 325-4393.

Dr. Pieramici's primary practice is California Retina Consultants in Bakersfield, California. Dr. Pieramici is also affiliated with Santa Barbara Cottage Hospital. The medical group on file is Sansum Clinic. Dmand AI also links Dr. Pieramici to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pieramici practices, 3 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Pieramici's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Pieramici is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Pieramici's licenses on file in 4 states: California, Maryland, Connecticut and Georgia.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and hereditary corneal conditions among the conditions Dr. Pieramici treats.

CMS data shows 47,565 Medicare services from Dr. Pieramici across 25 procedure codes in 2024, for 1,676 Medicare patients. Medicare paid $4,022,217 for them.

CMS counts 1,676 Medicare patients who saw Dr. Pieramici in 2024. The largest group is 75 to 84, with 626 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pieramici's median patient age at 70, with 53% women.

In 2024, Dr. Pieramici wrote 784 Medicare Part D claims for 243 patients. 64% of them were for generic drugs. CMS names the drug for 706 of them, across 15 drugs with 11 or more claims each, at $34,274 in total drug cost.

Dr. Pieramici accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 91 papers to Dr. Pieramici, published from 2006 to 2025. 2020 was the busiest year, with 5. The most frequent topics are Visual Acuity, Angiogenesis Inhibitors and Intravitreal Injections. Dr. Pieramici has published most often in Ophthalmology. Dr. Pieramici's most frequent co-authors are Robert Logan Avery, MD, Alessandro Attilio Castellarin, MD and Arshad Mohammad Khanani, MD.

Dmand AI links Dr. Pieramici to 9 clinical trials, 2 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Choroidal Neovascularization, Retinal Vein Occlusion and Choroid Diseases. California Retina Consultants sponsors the most, 6.

CMS Open Payments shows 159 general payments to Dr. Pieramici from 16 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 59% of the total. Genentech, Inc. paid the most, $58,190. It also lists 15 research payments totaling $42,642 from 2024 to 2025.

Dmand AI lists 3 awards for Dr. Pieramici, most recently Top Doctors:LA Area in 2013.

Dr. Pieramici graduated from The Johns Hopkins University School of Medicine in 1991. Dr. Pieramici is a member of AAO.

Dr. Pieramici is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.